产品名称 | NebuSelect™ Recombinant Human IL-6 R alpha/CD126, hFc-tag |
---|---|
目录号 | NBL-242435 |
别名 | IL-6 R alpha/CD126; IL-6R subunit alpha; IL-6R-alpha; IL-6RA; IL-6R 1; IL6R; CD126; IL6RQ; gp80 |
外观 | see COA |
分子量 | |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P08887-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242435-100ug | 100ug | Inquire | Inquire | |
NBL-242435-1mg | 1mg | Inquire | Inquire | |
NBL-242435-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human IL-6 R alpha/CD126, hFc-tag
Catalog#:
NBL-242435
Description:
NebuSelect™ Recombinant Human IL-6 R alpha/CD126, hFc-tag(Cat#NBL-242435) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Leu20-Pro365.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 65.3 kDa. Due to glycosylation, the protein migrates to 85-110 kDa based on Bis-Tris PAGE result.
Target Name:
IL-6 R alpha/CD126; IL-6R subunit alpha; IL-6R-alpha; IL-6RA; IL-6R 1; IL6R; CD126; IL6RQ; gp80
Target Information:
Serum levels of interleukin-6 (IL-6) are increased in patients with type 2 diabetes (T2D). IL-6 exerts its pleiotropic effects via the IL-6 α-receptor (IL-6R), which exists in membrane-bound and soluble (sIL-6R) forms and activates cells via the β-receptor glycoprotein 130 (gp130).
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.